230 related articles for article (PubMed ID: 2347547)
1. Estradiol-17 beta-D-glucuronide (E-17G) cholestasis in perfused rat liver: fate of E-17G and choleretic responses to bile salts.
Utili R; Tripodi MF; Adinolfi LE; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1990 May; 11(5):735-42. PubMed ID: 2347547
[TBL] [Abstract][Full Text] [Related]
2. Cholestasis induced by estradiol-17 beta-D-glucuronide: mechanisms and prevention by sodium taurocholate.
Adinolfi LE; Utili R; Gaeta GB; Abernathy CO; Zimmerman HJ
Hepatology; 1984; 4(1):30-7. PubMed ID: 6229465
[TBL] [Abstract][Full Text] [Related]
3. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
Vore M; Durham S; Yeh S; Ganguly T
Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-17 beta-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate.
Sano N; Takikawa H; Yamanaka M
J Hepatol; 1993 Feb; 17(2):241-6. PubMed ID: 8445238
[TBL] [Abstract][Full Text] [Related]
5. Improvement of estradiol-17 beta-D-glucuronide-induced cholestasis by sodium tauroursodeoxycholate therapy in rats.
Kinbara S; Ishizaki K; Sakakura H; Hirabayashi N; Kasai H; Araki T
Scand J Gastroenterol; 1997 Sep; 32(9):947-52. PubMed ID: 9299676
[TBL] [Abstract][Full Text] [Related]
6. Taurocholate and steroid glucuronides: mutual protection against cholestasis in the isolated perfused rat liver.
Durham S; Vore M
J Pharmacol Exp Ther; 1986 May; 237(2):490-5. PubMed ID: 3701641
[TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholate prevents taurocholate induced cholestasis.
Kitani K; Kanai S
Life Sci; 1982 Feb; 30(6):515-23. PubMed ID: 7070216
[TBL] [Abstract][Full Text] [Related]
8. Interactions between different bile salts in the biliary excretion of the rat.
Kitani K; Kanai S
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):139-52. PubMed ID: 6844732
[TBL] [Abstract][Full Text] [Related]
9. Mrp2 is essential for estradiol-17beta(beta-D-glucuronide)-induced cholestasis in rats.
Huang L; Smit JW; Meijer DK; Vore M
Hepatology; 2000 Jul; 32(1):66-72. PubMed ID: 10869290
[TBL] [Abstract][Full Text] [Related]
10. Effects of bile salt infusion on chlorpromazine-induced cholestasis in the isolated perfused rat liver.
Utili R; Tripodi MF; Abernathy CO; Zimmerman HJ; Gillespie J
Proc Soc Exp Biol Med; 1992 Jan; 199(1):49-53. PubMed ID: 1728036
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis.
Utili R; Adinolfi LE; Tripodi MF
Ital J Gastroenterol; 1995; 27(6):332-4. PubMed ID: 8563000
[TBL] [Abstract][Full Text] [Related]
12. Enhanced biliary excretion of canalicular membrane enzymes in estrogen-induced and obstructive cholestasis, and effects of different bile acids in the isolated perfused rat liver.
Accatino L; Figueroa C; Pizarro M; Solís N
J Hepatol; 1995 Jun; 22(6):658-70. PubMed ID: 7560859
[TBL] [Abstract][Full Text] [Related]
13. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat.
Alvaro D; Angelico M; Cantafora A; Gaudio E; Gandin C; Santini MT; Masella R; Capocaccia L
Hepatology; 1991 Jun; 13(6):1158-72. PubMed ID: 1646761
[TBL] [Abstract][Full Text] [Related]
14. Hepatic injury induced by bile salts: correlation between biochemical and morphological events.
Schmucker DL; Ohta M; Kanai S; Sato Y; Kitani K
Hepatology; 1990 Nov; 12(5):1216-21. PubMed ID: 2227821
[TBL] [Abstract][Full Text] [Related]
15. Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids.
Miyai K; Richardson AL; Mayr W; Javitt NB
Lab Invest; 1977 Mar; 36(3):249-58. PubMed ID: 839737
[TBL] [Abstract][Full Text] [Related]
16. Choleretic and cholestatic effects of infused bile salts in the rat.
Drew R; Priestly BG
Experientia; 1979 Jun; 35(6):809-11. PubMed ID: 467601
[TBL] [Abstract][Full Text] [Related]
17. Cell volume and bile acid excretion.
Häussinger D; Hallbrucker C; Saha N; Lang F; Gerok W
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):681-9. PubMed ID: 1463469
[TBL] [Abstract][Full Text] [Related]
18. Determinants of biliary secretory pressure: the effects of two different bile acids.
Cole MJ; Shaffer EA
Can J Physiol Pharmacol; 1988 Oct; 66(10):1303-7. PubMed ID: 3240413
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced cholestasis in the perfused rat liver and its reversal by tauroursodeoxycholate: an ultrastructural study.
Abernathy CO; Zimmerman HJ; Ishak KG; Utili R; Gillespie J
Proc Soc Exp Biol Med; 1992 Jan; 199(1):54-8. PubMed ID: 1728037
[TBL] [Abstract][Full Text] [Related]
20. Maximal hepatic bilirubin transport in the rat during somatostatin-induced cholestasis and taurocholate-choleresis.
Ricci GL; Cornelis M; Fevery J; De Groote J
J Lab Clin Med; 1983 Jun; 101(6):835-46. PubMed ID: 6133900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
